Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency

Minerva Cardioangiologica

Volumn 55, Issue 6, 2007, Pages 741-753

  Andreozzi, G M ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Postphlebitic syndrome; Varicose ulcer; Veins diseases; Venous insufficiency; Venous thrombosis

Indexed keywords

ANTIVITAMIN K; HEPARIN; MESOGLYCAN;

ARTICLE; CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE CLASSIFICATION; DRUG EFFICACY; FOLLOW UP; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; POSTTHROMBOSIS SYNDROME; PREVALENCE; STUDENT T TEST;

CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; GLYCOSAMINOGLYCANS; HUMANS; MALE; OUTPATIENTS; PATIENT SELECTION; POSTPHLEBITIC SYNDROME; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VARICOSE ULCER; VENOUS INSUFFICIENCY; VENOUS THROMBOSIS;

EID: 38649119103     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kauhanen P, Kovanen PT, Lassila R. Coimmobilized native macromolecular heparin proteoglycans strongly inhibit platelet-collagen interactions in flowing blood. Arterioscler Thromb Vasc Biol 2000;20:E113-9.
2. Cella G, Scattolo N, Luzzatto G, Stevanato F, Vio C, Girolami A. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf. J Med 1986;17:331-46.
3. Postiglione A, De Simone B, Rubba P, Lamenza F, Montefusco S, Mastranzo P. Effect of oral mesoglycan on plasma lipoprotein concentration and on lipoprotein lipase activity in primary hyperlipoproteinemia. Pharmacol Res Commun 1984;16:1-8.
4. Musanti R, Bernini F, Corsini A, Soma M, Fumagalli R. In vitro inhibition of rat arterial smooth muscle cell growth by extractive sulfated mucopolysaccharides. Pharmacol Res Commun 1985;17:69-84.
5. Pangrazzi J, Gianese F. Dermatan sulfate as a potential antithrombotic drug. Haematologica 1987;72:459-64.
6. Tollefsen DM, Pestka CA, Monafo WJ, Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983;258:6713-6.
7. Abbadini M, Zhu GJ, Maggi A, Pangrazzi J, Donati MB, Mussoni L. Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters. Blood 1987;70:1858-60.
8. Andreozzi GM, Signorelli S, Martini R, Palazzo V, Garozzo G, Sciuto V et al. [Protective effect of mesoglycan sulfate in venous thrombogenesis]. Minerva Med 1986;77:1883-6.
9. Agrifoglio G, Di Perri T, Strano A. Studio multicentrico sull'efficacia e la tollerabilità del mesoglicano in pazienti affetti da malattia venosa. Farmaci 1989;13:1-8.
10. Scondotto G, Catena G, Aloisi D. [Use of mesoglycan in venous pathology]. Minerva Med 1997;88:537-41.
11. Arosio E, Ferrari G, Santoro L, Gianese F, Coccheri S; Mesoglycan Venous Insufficiency Group. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers. Eur J Vasc Endovasc Surg 2001;22:365-72.
12. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999;53:149-53.
13. Bergan JJ, Schmid-Schonbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N Engl J Med 2006;355:488-98.
14. Andreozzi GM, Cordova RM, Scomparin A, Martini R, D'Eri A, Andreozzi F; Quality of Life Working Group on Vascular Medicine of SIAPAV. Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region. Int Angiol 2005;24:272-7.
15. Porter JM, Moneta GL. International Consensus Committee on Chronic Venous Disease: reporting standards in venous disease: an update. J Vasc Surg 1995;2:635-45.
16. Italian College of Phlebology. Guidelines for the diagnosis and treatment of chronic venous insufficiency. Int Angiol 2001;20:3-73.
17. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996;125:1-7.
18. Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Larfars G, Nicol P et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 1995;332:1661-5.
19. Kearon C, Gent M, Hirsh J, Weitz J, Kovacs MJ, Anderson DR et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999;340:901-7. Erratum in: N Engl J Med 1999;341:298.
20. Agnelli G, Prandoni P, Santamaria MG, Bagatella P, Iorio A, Bazzan M et al.; Warfarin Optimal Duration Italian Trial Investigators. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators. N Engl J Med 2001;345:165-9.
21. Pinede L, Ninet J, Duhaut P, Chabaud S, Demolombe-Rague S, Durieu I et al.; Investigators of the "Duree Optimale du Traitement AntiVitamines K" (DOTAVK) Study. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 2001;103:2453-60.
22. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001;119(1 Suppl):176S-193S.
23. Andreozzi GM, Signorelli S, Martini R, Garozzo S, Burrafato S. Epidemiological study on chronic venous incompetence. (Evaluation at the first step). Int Angiol 1994;13:60.
24. Cordova R et al. Finalised Project of Azienda Ospedaliera, University of Padova, 2003.
25. Andreozzi GM. Insufficienza venosa cronica; dalla macro alla microcircolazione. (Epidemiologia, fisiopatologia e clinica). Basi Razionali Terapia 2004:3-12.
26. Burnand KG, Whimster I, Naidoo A, Browse NL. Pericapillary fibrin cuff in the ulcer hearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J 1982;285:1071-2.
27. Andreozzi GM, Martini R, Bandieramonte G, Buttò G, Garagozzo N, Di Pino L et al. L'insuffisance veineuse chronique: pathologie macro ou microcirculatoire? In: Raymond-Mortimbeau P, Prescott R, Zummo M, editors. Phlebologie '92. Paris: J Libbey Eurotext; 1992.p.179.
28. Martini R, Palazzo V, Monaco S, Ferrara M, Di Pino L, Buttò G et al. La capillaroscopia nella insufficienza venosa cronica. Acta Cardiol Medit 1986;4:195.
29. Andreozzi GM, Signorelli S, Lo Duca S, Minacapelli C, Amico-Roxas MT, Minardo G et al. Effects of mesoglycan sulphate on the arterial elastic module. Angiology 1987;38:593-600.